Gene Symbol | CHRM3 |
Entrez ID | 1131 |
Uniprot ID | P20309 |
Description | cholinergic receptor, muscarinic 3 |
Chromosomal Location | chr1: 239,386,565-239,915,452 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0003056 |
regulation of vascular smooth muscle contraction |
Any process that increases the frequency, rate or extent of vascular smooth muscle contraction. |
IBA |
BP |
GO:0006464 |
cellular protein modification process |
The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications) occurring at the level of an individual cell. Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification). |
TAS |
BP |
GO:0006939 |
smooth muscle contraction |
A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. Smooth muscle differs from striated muscle in the much higher actin/myosin ratio, the absence of conspicuous sarcomeres and the ability to contract to a much smaller fraction of its resting length. |
IEA |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
TAS |
BP |
GO:0007186 |
G-protein coupled receptor signaling pathway |
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576). |
TAS |
BP |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway |
The series of molecular signals generated as a consequence of a G-protein coupled acetylcholine receptor binding to its physiological ligand, where the pathway proceeds with inhibition of adenylyl cyclase and a subsequent decrease in the concentration of cyclic AMP (cAMP). |
IBA |
BP |
GO:0007207 |
phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway |
The series of molecular signals generated as a consequence of a G-protein coupled acetylcholine receptor binding to its physiological ligand, where the pathway proceeds with activation of phospholipase C (PLC) and a subsequent release of inositol trisphosphate (IP3) and diacylglycerol (DAG). |
IBA |
BP |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway |
Any series of molecular signals initiated by an acetylcholine receptor on the surface of the target cell binding to one of its physiological ligands, and proceeding with the activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction and ends with regulation of a downstream cellular process, e.g. transcription. |
ISS |
BP |
GO:0007271 |
synaptic transmission, cholinergic |
The process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse using the neurotransmitter acetylcholine. |
IBA |
BP |
GO:0007399 |
nervous system development |
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state. |
TAS |
BP |
GO:0008283 |
cell proliferation |
The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
TAS |
BP |
GO:0045987 |
positive regulation of smooth muscle contraction |
Any process that activates or increases the frequency, rate or extent of smooth muscle contraction. |
IEA |
BP |
GO:0046541 |
saliva secretion |
The regulated release of saliva from the salivary glands. In man, the saliva is a turbid and slightly viscous fluid, generally of an alkaline reaction, and is secreted by the parotid, submaxillary, and sublingual glands. In the mouth the saliva is mixed with the secretion from the buccal glands. In man and many animals, saliva is an important digestive fluid on account of the presence of the peculiar enzyme, ptyalin. |
IEA |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
TAS |
CC |
GO:0005887 |
integral component of plasma membrane |
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
ISS |
CC |
GO:0016323 |
basolateral plasma membrane |
The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
IEA |
CC |
GO:0030054 |
cell junction |
A cellular component that forms a specialized region of connection between two or more cells or between a cell and the extracellular matrix. At a cell junction, anchoring proteins extend through the plasma membrane to link cytoskeletal proteins in one cell to cytoskeletal proteins in neighboring cells or to proteins in the extracellular matrix. |
IEA |
CC |
GO:0030425 |
dendrite |
A neuron projection that has a short, tapering, often branched, morphology, receives and integrates signals from other neurons or from sensory stimuli, and conducts a nerve impulse towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
IEA |
CC |
GO:0032279 |
asymmetric synapse |
A type of synapse occurring between an axon and a dendritic spine or dendritic shaft. Asymmetric synapses, the most abundant synapse type in the central nervous system, involve axons that contain predominantly spherical vesicles and contain a thickened postsynaptic density. Most or all synapses of this type are excitatory. |
IEA |
CC |
GO:0043679 |
axon terminus |
Terminal inflated portion of the axon, containing the specialized apparatus necessary to release neurotransmitters. The axon terminus is considered to be the whole region of thickening and the terminal button is a specialized region of it. |
IEA |
CC |
GO:0045202 |
synapse |
The junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell; the site of interneuronal communication. As the nerve fiber approaches the synapse it enlarges into a specialized structure, the presynaptic nerve ending, which contains mitochondria and synaptic vesicles. At the tip of the nerve ending is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic nerve ending secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. |
IBA |
CC |
GO:0045211 |
postsynaptic membrane |
A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane. |
IEA |
MF |
GO:0004435 |
phosphatidylinositol phospholipase C activity |
Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H(2)O = 1,2-diacylglycerol + 1D-myo-inositol 1,4,5-trisphosphate + H(+). |
TAS |
MF |
GO:0004872 |
receptor activity |
Combining with an extracellular or intracellular messenger to initiate a change in cell activity. |
TAS |
MF |
GO:0008144 |
drug binding |
Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease. |
IEA |
MF |
GO:0016907 |
G-protein coupled acetylcholine receptor activity |
Combining with acetylcholine and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. |
ISS |
MF |
GO:0042166 |
acetylcholine binding |
Interacting selectively and non-covalently with acetylcholine, an acetic acid ester of the organic base choline that functions as a neurotransmitter, released at the synapses of parasympathetic nerves and at neuromuscular junctions. |
ISS |
Domain ID | Description |
---|---|
IPR000276 |
G protein-coupled receptor, rhodopsin-like |
IPR000995 |
Muscarinic acetylcholine receptor family |
IPR001183 |
Muscarinic acetylcholine receptor M3 |
IPR017452 |
GPCR, rhodopsin-like, 7TM |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04020 |
Calcium signaling pathway |
KEGG |
hsa04080 |
Neuroactive ligand-receptor interaction |
KEGG |
hsa04725 |
Cholinergic synapse |
KEGG |
hsa04742 |
Taste transduction |
KEGG |
hsa04810 |
Regulation of actin cytoskeleton |
KEGG |
hsa04911 |
Insulin secretion |
KEGG |
hsa04970 |
Salivary secretion |
KEGG |
hsa04971 |
Gastric acid secretion |
KEGG |
hsa04972 |
Pancreatic secretion |
KEGG |
WP536 |
Calcium Regulation in the Cardiac Cell |
WikiPathways |
WP455 |
GPCRs, Class A Rhodopsin-like |
WikiPathways |
WP51 |
Regulation of Actin Cytoskeleton |
WikiPathways |
WP58 |
Monoamine GPCRs |
WikiPathways |
WP117 |
GPCRs, Other |
WikiPathways |
UMLS CUI | UMLS Term |
---|---|
C0003962 |
Ascites |
C0005686 |
Urinary Bladder Diseases |
C0010417 |
Cryptorchidism |
C0014544 |
Epilepsy |
C0023890 |
Liver Cirrhosis |
C0033770 |
Prune Belly Syndrome |
C0860207 |
Drug-Induced Liver Injury |
Tissue | Cell Type |
---|---|
skin |
fibroblasts |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
EDNRA |
1909 |
P25101 |
0.00 |
F2R |
2149 |
P25116 |
0.00 |
GNA11 |
2767 |
P29992 |
0.00 |
PTGER1 |
5731 |
P34995 |
0.00 |
TACR1 |
6869 |
P25103 |
0.00 |
TBXA2R |
6915 |
P21731 |
0.00 |
GNG2 |
54331 |
P59768 |
0.00 |
PPP1R9B |
84687 |
Q96SB3 |
0.56 |
NALCN |
259232 |
Q8IZF0 |
0.63 |
SET |
6418 |
Q01105 |
0.68 |
ARF1 |
375 |
P84077 |
0.79 |
AGTR1 |
185 |
P30556 |
0.00 |
MDM2 |
4193 |
Q00987 |
0.49 |
GNAQ |
2776 |
P50148 |
0.52 |
GRK6 |
2870 |
P43250 |
0.52 |
GPRASP1 |
9737 |
Q5JY77 |
0.52 |
GZMB |
3002 |
P10144 |
0.55 |
CSNK1A1 |
1452 |
P48729 |
0.75 |
ARF6 |
382 |
P62330 |
0.79 |